04.01.2022 • NewsCrodaCargill

Cargill Takes Croda’s PTIC Business

US food giant Cargill has agreed to buy most of Croda’s Performance Technologies and Industrial Chemicals (PTIC) business for €915 million on a cash-free, debt-free basis. The acquisition of the UK group will boost Cargill’s bio-industrial footprint, better serving manufacturers seeking greener ingredients.

Croda’s decision to divest the business, which includes plants in the UK, Netherlands and China, follows a strategic review last year.

“The bioindustrial space is a priority for Cargill, as we strive to support our customers with innovative, nature-based solutions that deliver real-world benefits,” said Colleen May, president of Cargill’s Bio-industrial business. “Combining our diverse, global supply chain and deep operational expertise with Croda’s extensive industrial business capabilities and broad bio-based portfolio will spark a new wave of innovation and create tremendous value for our customers.”

Under the transaction, which is expected to close this summer, Cargill will add nearly 1,000 employees and a strong technology portfolio that supports leading market positions in automotive, polymer and food packaging applications. More than two-thirds of the raw materials Croda uses to make its products are bio-based and renewable.

Cargill’s move builds on other acquisitions to expand its bio-industrial presence. Last September, the Minneapolis-headquartered group agreed to buy Arkema’s epoxides business, gaining production capabilities in bio-based plasticizers and polyols. The month before, it had authorized NatureWorks – Cargill’s joint venture with Thailand’s PTT Global Chemical – to build a new Ingeo polylactic acid manufacturing complex in the Nakhon Sawan Biocomplex. 

Last June, Cargill and Germany’s Helm formed a joint venture called Qore to build a first commercial-scale renewable butanediol facility in the US. The plant, at Cargill’s complex in Eddyville, Iowa, is due to start operating in 2024.

Author: Elaine Burridge, Freelance Journalist

(c) Croda
(c) Croda

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.